Surmodics Inc. said its CFO would leave the company May 25.
Andrew LaFrence will be replaced by Surmodics' vice president of corporate development and strategy, Timothy Arens, on an interim basis.
LaFrence is leaving the company to join Biothera Pharmaceuticals Inc. as senior vice president and CFO, effective May 29.
